Beyond Protein Presence: The Role of Endocytic Dynamics
A groundbreaking study led by researchers at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Proteomics Platform of the Institute for Research in Biomedicine (IRB Barcelona), has uncovered a key mechanism that defines how the blood-brain barrier (BBB) functions. The research, published in iScience, shows that brain endothelial cells possess a unique "endocytic profile" that describes how quickly proteins are internalized, recycled, or degraded. This property, known as the endocytic turnover rate (ETOR), emerges as a critical driver of BBB specialization and is disrupted under inflammatory conditions.
"Through a collaboration bringing together cell biology, proteomics, bioinformatics and mathematics, we asked whether blood-brain barrier specialization arises not only from the proteins it expresses, but also from how it uses them," says Daniel Gonzalez-Carter, senior research fellow in the Molecular Bionics Group at IBEC and leader of the study. "These findings may help identify novel therapeutic strategies to restore neurovascular health," adds Giuseppe Battaglia, ICREA research professor at IBEC, principal investigator at the Molecular Bionics Group and co-author of the study.
Understanding the Blood-Brain Barrier's Selective Gate
The blood-brain barrier is a highly selective interface that protects the brain while allowing essential nutrients and signals to pass. Traditionally, its function has been explained by the identity and abundance of proteins on the surface of endothelial cells. However, it remains unclear whether the dynamic regulation of these proteins—the so-called ETOR profile—contributes to the unique properties of brain endothelial cells. It is also unknown whether this dynamic regulation changes in disease in ways that affect the BBB.
Using advanced proteomics, the team tracked how nearly 1,000 membrane proteins behave over time in rat endothelial cells from the brain and other tissues. They found that brain endothelial cells exhibit a distinct ETOR compared to peripheral endothelial cells, with specific proteins being turned over at different rates. This dynamic behavior is not merely a consequence of protein expression levels but represents an independent layer of regulation that fine-tunes barrier function.
Implications for Inflammatory Conditions and Therapy
The study also demonstrated that inflammatory conditions disrupt the ETOR profile of brain endothelial cells, leading to altered protein dynamics that may compromise BBB integrity. This finding suggests that restoring the normal ETOR could be a therapeutic target for neuroinflammatory diseases. "These findings may help identify novel therapeutic strategies to restore neurovascular health," Battaglia emphasized.
The research team combined cell biology, proteomics, bioinformatics, and mathematical modeling to analyze the endocytic turnover rates. By tracking the behavior of membrane proteins over time, they could quantify how long each protein remains active at the cell surface before being internalized and either recycled or degraded. This approach revealed that the BBB's specialization arises not only from the proteins it expresses but also from how dynamically it uses them.
Future Directions and Broader Impact
This study opens new avenues for understanding how the blood-brain barrier maintains its selective permeability and how it fails in disease. The ETOR concept could be applied to other biological barriers and may lead to novel drug delivery strategies that exploit the dynamic nature of endothelial cells. As Gonzalez-Carter noted, the collaboration across disciplines was key to uncovering this mechanism, and future work will explore how ETOR changes in specific neurological disorders.
By focusing on the dynamic behavior of proteins rather than static expression levels, the research provides a more nuanced view of cellular function. This paradigm shift could influence how scientists study other specialized cell types and barriers throughout the body.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
